1. Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine. Issue 10 (16th July 2013) Authors: Duong, Hong‐Quan; Hong, Young Bin; Kim, Jung Soon; Lee, Hee‐Seok; Yi, Yong Weon; Kim, Yeon Jeong; Wang, Antai; Zhao, Wenjing; Cho, Chi Heum; Seong, Yeon‐Sun; Bae, Insoo Journal: Journal of cellular and molecular medicine Issue: Volume 17:Issue 10(2013) Page Start: 1261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of constitutively activated phosphoinositide 3‐kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1‐defective breast cancer cells12. Issue 9 (4th April 2012) Authors: Yi, Yong Weon; Kang, Hyo Jin; Kim, Hee Jeong; Hwang, Jae Seok; Wang, Antai; Bae, Insoo Journal: Molecular carcinogenesis Issue: Volume 52:Issue 9(2013:Sep.) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple‐negative breast cancer cells. Issue 5 (20th April 2013) Authors: Yi, Yong Weon; Hong, Wooyoung; Kang, Hyo Jin; Kim, Hee Jeong; Zhao, Wenjing; Wang, Antai; Seong, Yeon‐Sun; Bae, Insoo Journal: Journal of cellular and molecular medicine Issue: Volume 17:Issue 5(2013) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗